SW
SpringWorks
SWTX·NASDAQStamford CTFounded 2017300 employees
Mid CapbiotechPublicOncologyRare Disease
Platform: Nirogacestat
Market Cap
$3B
All Drugs
3
Clinical Trials
6
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (SWTX)
Loading SWTX stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| SWT-8357 | SWT-8357 | Phase 1 | 2 | Cl18.2 | ET | ||
| Polarapivir | SWT-1285 | NDA/BLA | 2 | FcRn | CMLGA | ||
| SWT-3857 | SWT-3857 | Phase 1 | 2 | CDK4/6 | FLGIST |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (8)